Counties with animal feeding operations have more air pollution, less health insurance coverage
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Aug-2025 16:10 ET (24-Aug-2025 20:10 GMT/UTC)
Universities that have eliminated standardized test requirements for admissions in recent years generally experienced gains in diversity in their student bodies, according to research by the University of California, Davis. However, if the universities also faced recent financial shortfalls or enrollment declines, or continued to prioritize quantitative academic criteria such as test scores and class rank, these gains in diversity diminished or disappeared.
The paper, “Same Policy, No Standardized Outcome: How Admissions Values and Institutional Priorities Shape the Effect of Test-Optional Policies on Campus Diversity,” was published in the American Sociological Review on Aug. 11.
“Although test-optional admissions policies are often adopted with the assumption that they will broaden access to underrepresented minority groups, the effectiveness of these policies in increasing student diversity appears to depend on existing admissions values and institutional priorities at the university,” said Greta Hsu, co-author of the paper. Hsu is a UC Davis professor in the Graduate School of Management who studies organizational behavior.
Portland State University researchers have released the final findings in a three-year project examining the impacts of multiple drug policy shifts including Measure 110 which decriminalized drug possession in Oregon.
The final report finds little evidence that Measure 110 was responsible for rising crime or overdose deaths. Instead, researchers found that trends in crime rates and overdose fatalities were primarily driven by the COVID-19 pandemic and the rise of fentanyl. The report also offers crucial insights for the implementation of the state’s new drug policy (HB 4002), emphasizing that policy change alone isn't enough — successful deflection to treatment depends on robust resources and coordination.
The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant advances in the development and application of human stem cell-based embryo models (SCBEMs) and recommendations for research oversight outlined in a white paper from the ISSCR Embryo Models Working Group published in June.